Senate clears way for von Eschenbach vote

Share this article:
The US Senate today voted to end debate on the nomination of Andrew von Eschenbach to permanently head the FDA, clearing the way for a final vote. Von Eschenbach supporters overcame objections from three Republican senators who opposed his nomination. In a procedural move, the Senate voted, 89-6, to end debate over the nomination. A Senate vote to confirm von Eschenbach as FDA commissioner was expected later today, Reuters reported. Von Eschenbach has served as acting FDA commissioner since September 2005. He was nominated earlier this year by President Bush to take the job permanently.
Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.